What is P3P?
Personal Patient Profile Prostate (P3P) is a tool to help newly
diagnosed prostate cancer patients make an informed decision
with their physician about their treatment options. P3P was
made available by TrueNTH, a Movember project dedicated to
improving the quality of prostate cancer care. With MUSIC’s
goal to make Michigan the best place in the world
for prostate cancer care, MUSIC urologists partnered with
TrueNTH to provide P3P to their patients.
Step 1 – Email Notification
You will receive an email from TrueNTH inviting you to participate in P3P.
Step 2 – P3P Questionnaire
The one-time questionnaire will take about 15 minutes of your time and help prepare you for your visit with your doctor. To view a copy of the questions you will be asked, please click here. Once you complete the questionnaire online, your responses will be presented in a report to you and your doctor.
Step 3 – Your Next Appointment with your Physician
You and your doctor will review your responses to the P3P questionnaire and together discuss treatment options that are best for you in your prostate cancer care.
Download a Brochure
For a patient educational brochure on the P3P project, please click on the link below:
Once you complete the P3P questionnaire, you will have the option to register for a TrueNTH account. A TrueNTH account will provide a patient to the following tools:
- Access to your completed P3P report.
- Symptom Tracker: A tool that tracks a patient’s prostate cancer symptoms/side effects and compares these experiences to others, just like you.
- Lifestyle, Exercise, Diet: A tool with general information geared around health and lifestyle specific for men with prostate cancer.
If you have further questions or concerns regarding P3P please contact the MUSIC Coordinating Center at 855.456.2035 or firstname.lastname@example.org.
The Personal Patient Profile-Prostate (P3P) was originally developed by Donna Berry, PhD, RN, AOCN, FAAN Director of the Phyllis F. Cantor Center for Research in Nursing & Patient Care Services, at the Dana-Farber Cancer Center in Boston.